Bradford B. Walters

Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC.

The North Carolina Medical Society is a non-profit company based in Raleigh, NC. North Carolina Medical Society unites, serves, and represents physicians and their healthcare teams to enhance the health of North Carolinians. The CEO of the company is Bob Seligson.

Curry Pharmaceuticals Corp. develops pharmaceutical products. It offers novel drugs for cancer, oncology, dermatology and other inflammatory diseases based on the natural product curcumin. The company was founded in 2003 by Dennis P. Schafer, Lowell A. Goldsmith, and Bharat Aggarwal and is headquartered in Durham, NC.

Academy Funds is a family of venture capital funds located in Durham, North Carolina with an additional office in Greenville, South Carolina

Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL.